NEW YORK, Aug. 30, 2016 /PRNewswire-USNewswire/ -- Cycle for Survival is proud to announce the creation of the Equinox Innovation Initiative, established at Memorial Sloan Kettering Cancer Center (MSK). The initiative honors Equinox's significant partnership with Cycle for Survival in support of rare cancer research.
The focus of the Equinox Innovation Initiative will be Cycle for Survival's distinguished research awards that are presented annually to MSK's top physicians and scientists through a competitive application process conducted by the institution.
Cycle for Survival, which is owned and operated by MSK, has raised more than $105 million in the past 10 years; every dollar goes to rare cancer research studies and clinical trials led by MSK. Equinox's unwavering support as Cycle for Survival's founding partner has enabled the movement's continued growth.
The Equinox Innovation Initiative, administered by MSK, backs the best investigators, projects, programs and ideas—with an emphasis on rare cancers. The research award recipients aim to improve the diagnosis and treatment of rare cancer patients worldwide. The grants they receive are funded by money raised by Cycle for Survival participants each year. The 2016 grants include a variety of topics and areas of research, such as: bile duct cancer, germ cell tumors, kidney cancer, lymphoma, pancreatic cancer, pediatric sarcoma, and others.
Next year marks Cycle for Survival's 11th year of team indoor cycling rides. In 2017, more than 31,000 riders in 16 cities across the country will participate in February and March. Led by Equinox instructors, the Cycle for Survival community will come together to experience heart-pumping music, dancing, and inspiring stories and tributes. Registration for the events opens next month with the Times Square Takeover kickoff event on September 30.
To learn more about the Equinox Innovation Initiative, please visit cycleforsurvival.org/equinox-innovation-initiative.
DR. JOSÉ BASELGA, PHYSICIAN-in-CHIEF, MSK
"By establishing the Equinox Innovation Initiative, Memorial Sloan Kettering is proud to recognize the unparalleled effort of Equinox as a worldwide corporate leader in the battle to beat rare cancers. Through the extraordinary effort of its employees across the country, Equinox has directly and profoundly altered the landscape of rare cancer research. We are honored to partner with Equinox, and grateful for their enduring dedication."
SCOTT ROSEN, CHIEF OPERATING OFFICER, EQUINOX
"Cycle for Survival has become an integral part of our identity, and the single most important initiative that we have ever undertaken. Our teams, 13,000 strong, are deeply committed to beating rare cancers. We're tremendously honored and humbled to have our name on this game-changing initiative at Memorial Sloan Kettering. As Cycle for Survival's founding partner, we are proud to be in this fight and will continue our efforts until there is a cure."
About Cycle for Survival
Join the Battle. Cycle for Survival is the movement to beat rare cancers. Since 2007, Cycle for Survival has raised more than $105 million through its signature indoor team cycling events across the United States to help fund pioneering rare cancer research led by Memorial Sloan Kettering Cancer Center, which owns and operates Cycle for Survival. 100 percent of every donation funds rare cancer research. About half of all cancer patients are fighting a rare cancer, and they often face limited or no treatment options. Together with the movement's founding partner, Equinox, Cycle for Survival has supported innovative clinical trials, research studies, and major research initiatives. For a list of events, research updates, and additional information, visit www.cycleforsurvival.org and follow Cycle for Survival on Facebook, Twitter, Instagram, and YouTube.
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering (MSK)—the world's oldest and largest private cancer center—has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, it is one of 45 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side-by-side with clinical studies and treatment. The close collaboration between MSK's physicians and scientists is one of its unique strengths, enabling it to provide patients with the best care available as researchers work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. MSK's education programs train future physicians and scientists, and the knowledge and experience they gain has an impact on cancer treatment and biomedical research around the world.
Equinox operates 82 upscale, full-service clubs in New York, Chicago, Los Angeles, San Francisco, Miami, Boston, Texas and Washington, DC, as well as international locations in London and Toronto. The company offers an integrated selection of Equinox-branded programs, services and products, including strength and cardio training, studio classes, personal training, spa services and products, apparel and food/juice bars. Equinox's hotel properties will cater exclusively to the high performance traveler and will fuse luxury and wellness to serve as the ultimate hotel destination with a 360-degree lifestyle experience. Offering the bespoke experiences and unparalleled services consumers have come to expect from Equinox over its 25-year history, Equinox's hospitality brand will grow to 50 worldwide locations. Since its inception in 1991, Equinox has developed a lifestyle brand that represents service, value, quality, expertise, innovation, attention to detail, market leadership and results.
IT'S NOT FITNESS. IT'S LIFE.
SOURCE Cycle for Survival